HALOZYME THERAPEUTICS, INC. HALO Income Statement

Halozyme therapeutics, inc. (HALO)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues:
Total revenues
164,397	195,992	202,559	181,885	177,939	151,862	281,194	319,369	317,917	316,613	166,052	134,174	133,760	146,691	159,915	148,842	158,890	135,057	113,207	107,033	82,034	75,334	57,455	58,862	54,931	54,799	64,094	53,415	46,718	42,325	22,942	40,550	55,982	56,086	57,071	37,342	0	0	0
Operating expenses:
Cost of product sales
46,684	45,546	34,481	12,774	11,733	10,136	12,002	19,708	26,660	31,152	31,666	32,468	32,988	33,206	33,631	30,677	30,513	29,245	26,965	25,926	23,706	22,732	20,125	15,667	11,027	6,246	3,359	2,903	1,762	1,094	496	281	316	257	208	280	0	0	0
Research and development
119,634	140,804	132,343	137,428	143,604	150,252	154,978	153,431	151,684	150,643	150,616	150,486	147,677	150,842	137,239	130,987	116,652	93,236	85,218	77,511	74,965	79,696	80,894	86,679	96,021	96,640	94,281	88,096	76,186	70,044	66,392	60,403	59,668	57,563	55,096	53,506	0	0	0
Selling, general and administrative
71,878	77,252	71,354	68,239	65,254	60,804	57,544	56,009	54,757	53,816	51,272	49,542	47,662	45,853	44,215	42,842	41,435	40,028	37,792	36,153	35,091	35,942	36,945	36,493	35,041	32,347	29,969	27,468	25,749	24,812	23,700	22,329	21,316	18,104	15,611	14,705	0	0	0
Total operating expenses
238,196	263,602	238,178	218,441	220,591	221,192	224,524	229,148	233,101	235,611	233,554	232,496	228,327	229,901	215,085	204,506	188,600	162,509	149,975	139,590	133,762	138,370	137,964	138,839	142,089	135,233	127,610	118,468	103,698	95,950	90,589	83,014	81,302	75,925	70,916	68,492	0	0	0
Operating (loss) income
-73,799	-67,610	-35,619	-36,556	-42,652	-69,330	56,670	90,221	84,816	81,002	-67,502	-98,322	-94,567	-83,210	-55,170	-55,664	-29,710	-27,452	-36,768	-32,557	-51,728	-63,036	-80,509	-79,977	-87,158	-80,434	-63,516	-65,052	-56,979	-53,625	-67,646	-42,463	-25,319	-19,838	-13,844	-31,149	0	0	0
Other income (expense):
Interest income, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-
Investment and other income, net
7,408	6,986	7,670	7,967	7,967	7,578	6,641	5,521	3,973	2,592	1,878	1,422	1,384	1,326	1,115	859	549	422	222	266	297	242	351	281	221	229	165	137	106	73	84	0	0	-	0	-	-	0	0
Interest expense
13,770	11,627	11,651	13,859	16,016	18,041	19,744	20,996	21,766	21,984	22,125	21,840	21,549	19,977	15,680	11,728	7,778	5,201	5,277	5,352	5,504	5,581	4,930	4,404	3,802	3,274	2,547	1,697	848	0	0	0	0	-	-	-	-	-	-
Net (loss) income before income taxes
-80,161	-72,251	-39,600	-42,448	-50,701	-79,793	43,567	74,746	67,023	61,610	-87,749	-118,740	-114,732	-101,861	-98,513	-67,832	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax expense
-22	-11	369	356	372	537	-2,111	-1,531	-1,384	-1,361	548	1,252	1,372	1,162	1,584	300	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income (Loss) Attributable to Parent
-80,139	-72,240	-39,969	-42,804	-51,073	-80,330	45,678	76,277	68,407	62,971	-88,297	-119,992	-116,104	-103,023	-71,319	-66,833	-36,939	-32,231	-41,823	-37,643	-56,935	-68,375	-85,088	-84,100	-90,739	-83,479	-65,897	-66,611	-57,720	-53,552	-67,561	-42,390	-25,253	-19,769	-13,763	-31,079	0	0	0
Net (loss) income per share:
Basic and diluted (usd per share)
-0.04	-0.24	-0.17	-0.10	0.01	-	-0.19	-0.16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.22	0.00	-0.17	-0.20	-0.17	0.00	-0.18	-0.13	-0.14	0.00	0.05	0.03	-0.10	-	-
Net income (loss) per share, Basic
-	-	-	-	-	-	-	-	-0.19	0.93	0.02	-0.23	-0.26	-0.21	-0.23	-0.21	-0.16	0.04	-0.19	0.02	-0.12	-	-0.16	-0.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.13	-0.13
Net income (loss) per share, Diluted
-	-	-	-	-	-	-	-	-0.19	-	0.02	-	-	-	-0.23	-	-	-	-	0.02	-	-	-	-0.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.13	-0.13
Shares used in computing net (loss) income per share:
Basic and diluted (in shares)
137,186	141,026	146,136	145,411	144,743	-	143,949	143,568	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	118,943	113,552	112,765	112,486	112,417	112,349	112,305	112,063	107,589	-	-	-	100,927	-	-
Shares used in computing basic net income (loss) per share
-	-	-	-	-	-	-	-	142,656	141,858	141,190	134,013	128,615	128,129	128,154	127,958	127,615	128,452	126,921	126,144	125,299	-	124,041	123,710	-	-	-	-	-	-	-	-	-	-	103,223	102,671	-	93,626	91,766
Shares used in computing diluted net income (loss) per share
-	-	-	-	-	-	-	-	142,656	-	143,236	-	-	-	128,154	-	-	-	-	134,507	-	-	-	123,710	-	-	-	-	-	-	-	-	-	-	105,009	104,393	-	93,626	91,766
Comprehensive Loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-
Royalties
Total revenues
68,768	69,899	72,007	74,108	75,990	78,981	77,311	75,720	70,469	63,507	60,128	56,045	53,579	50,984	46,239	41,477	35,587	30,975	25,474	20,095	15,401	9,425	5,415	2,520	832	33	0	0	0	-	-	-	-	-	-	-	-	-	-
Product sales, net
Total revenues
65,805	66,048	54,036	31,100	29,823	28,234	30,146	37,466	45,763	50,396	51,225	50,967	51,886	53,392	53,549	50,519	49,162	46,082	42,647	41,963	39,115	37,823	37,484	37,892	31,498	24,439	16,093	6,783	4,208	2,887	1,775	2,217	1,858	1,836	1,585	628	0	0	0
Collaborative Agreements [Member]
Total revenues
29,824	60,045	76,516	76,677	72,126	44,647	173,737	206,183	201,685	202,710	54,699	27,162	28,295	42,315	60,127	56,846	74,141	58,000	45,086	44,975	27,518	28,086	14,556	18,450	22,601	30,327	48,001	46,631	42,510	39,438	21,166	38,333	54,124	54,250	55,485	36,714	0	0	0